Samsung Biologics Co., Ltd.

Samsung Biologics Co., Ltd. is a key player in the biopharmaceutical manufacturing and services industry. Established as a subsidiary of Samsung Group, it focuses on the development and manufacturing of biologic drugs. The company provides contract development and manufacturing organization (CDMO) services, supporting pharmaceutical companies in bringing innovative treatments to market efficiently. Samsung Biologics operates through state-of-the-art facilities offering comprehensive services from cell line development to large-scale manufacturing, impacting the healthcare and biotechnology sectors significantly. Headquartered in South Korea, it plays a critical role in the global supply chain of biologics, an essential component in treating complex diseases like cancer and autoimmune disorders. The company's strategic partnerships and investments in advanced bioprocessing technologies enhance its market position as a leader in its field.

CEO

임존종보 (Rim John Chongbo)

Employees

5,047

Website

samsungbiologics.com